High efficacy of treatment with sofosbuvir+GS-5816 ±ribavirin for 12 weeks in treatment experienced patients with genotype 1 or 3 HCV infection

Authors
Category Primary study
ConferenceHepatology
Year 2014
This article has no abstract
Epistemonikos ID: 1b10e1f4a255264f3e67bd4b8029a965e53914bd
First added on: Apr 30, 2026